PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35599279-8	2022	RESULTS: In ARPE-19 cells exposed to high-glucose conditions, the mRNA and secretory protein levels of VEGF, p-JAK1, p-JAK2, p-STAT3, and p-STAT5 levels were significantly increased.	Glucose	42-49	vascular endothelial growth factor A	Homo sapiens	103-107	
35599279-8	2022	RESULTS: In ARPE-19 cells exposed to high-glucose conditions, the mRNA and secretory protein levels of VEGF, p-JAK1, p-JAK2, p-STAT3, and p-STAT5 levels were significantly increased.	Glucose	42-49	Janus kinase 1	Homo sapiens	111-115	
35599279-8	2022	RESULTS: In ARPE-19 cells exposed to high-glucose conditions, the mRNA and secretory protein levels of VEGF, p-JAK1, p-JAK2, p-STAT3, and p-STAT5 levels were significantly increased.	Glucose	42-49	Janus kinase 2	Homo sapiens	119-123	
35599279-8	2022	RESULTS: In ARPE-19 cells exposed to high-glucose conditions, the mRNA and secretory protein levels of VEGF, p-JAK1, p-JAK2, p-STAT3, and p-STAT5 levels were significantly increased.	Glucose	42-49	signal transducer and activator of transcription 3	Homo sapiens	127-132	
35599279-8	2022	RESULTS: In ARPE-19 cells exposed to high-glucose conditions, the mRNA and secretory protein levels of VEGF, p-JAK1, p-JAK2, p-STAT3, and p-STAT5 levels were significantly increased.	Glucose	42-49	signal transducer and activator of transcription 5A	Homo sapiens	140-145	
35599279-9	2022	Treatment with JAKiI, tofacitinib, and STAT3i significantly suppressed VEGF to basal levels at both the mRNA and secretory levels in vitro.	tofacitinib	22-33	vascular endothelial growth factor A	Homo sapiens	71-75	
35599279-10	2022	In STZ-induced mice, retinal vascular leakage, p-JAK1, p-JAK2, p-JAK3, p-STAT3, and VEGF were significantly increased after diabetes induction.	Streptozocin	3-6	Janus kinase 1	Mus musculus	49-53	
35599279-10	2022	In STZ-induced mice, retinal vascular leakage, p-JAK1, p-JAK2, p-JAK3, p-STAT3, and VEGF were significantly increased after diabetes induction.	Streptozocin	3-6	Janus kinase 2	Mus musculus	57-61	
35599279-10	2022	In STZ-induced mice, retinal vascular leakage, p-JAK1, p-JAK2, p-JAK3, p-STAT3, and VEGF were significantly increased after diabetes induction.	Streptozocin	3-6	Janus kinase 3	Mus musculus	65-69	
35599279-10	2022	In STZ-induced mice, retinal vascular leakage, p-JAK1, p-JAK2, p-JAK3, p-STAT3, and VEGF were significantly increased after diabetes induction.	Streptozocin	3-6	signal transducer and activator of transcription 3	Mus musculus	73-78	
35599279-10	2022	In STZ-induced mice, retinal vascular leakage, p-JAK1, p-JAK2, p-JAK3, p-STAT3, and VEGF were significantly increased after diabetes induction.	Streptozocin	3-6	vascular endothelial growth factor A	Mus musculus	84-88	
35599279-12	2022	Increased p-JAK1 and VEGF in STZ-induced mice were significantly reduced by JAKiI (p < 0.05, p < 0.001) and tofacitinib (p < 0.001, respectively).	Streptozocin	29-32	Janus kinase 1	Mus musculus	12-16	
35599279-12	2022	Increased p-JAK1 and VEGF in STZ-induced mice were significantly reduced by JAKiI (p < 0.05, p < 0.001) and tofacitinib (p < 0.001, respectively).	Streptozocin	29-32	vascular endothelial growth factor A	Mus musculus	21-25	
35599279-12	2022	Increased p-JAK1 and VEGF in STZ-induced mice were significantly reduced by JAKiI (p < 0.05, p < 0.001) and tofacitinib (p < 0.001, respectively).	tofacitinib	108-119	Janus kinase 1	Mus musculus	12-16	
35599279-12	2022	Increased p-JAK1 and VEGF in STZ-induced mice were significantly reduced by JAKiI (p < 0.05, p < 0.001) and tofacitinib (p < 0.001, respectively).	tofacitinib	108-119	vascular endothelial growth factor A	Mus musculus	21-25